Related Experiment Video
Updated: May 26, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell
Naveen Muppani1, Ulrika Nyman, Bertrand Joseph
1Department of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, 171 76 Stockholm, Sweden.
Abstract:
Caspase-2 is ubiquitously expressed and the most evolutionarily conserved mammalian caspase. It can be activated by a range of death stimuli prior to Bax activation and the occurrence of apoptotic mitochondrial dysfunctions. Caspase-2 has also been reported to exert tumour suppressor function in vivo. The full length TAp73alpha isoform is found up-regulated in various tumour types, and is reported in a cell-type specific manner to repress drug-induced apoptosis. Here, we report that TAp73alpha represses caspase-2 enzymatic activity and by this means reduce caspase-2 induced Bax activation, loss of mitochondrial transmembrane potential and resulting apoptosis. The inhibitory effect on caspase-2 requires the presence of the DNA binding domain and SAM domain region of TAp73alpha. In conclusion, the ability of TAp73alpha to act as an inhibitor of caspase-2-induced cell death together with its up-regulation in certain tumour types strengthen the potential oncogenic activities for this protein.
Insights
The TAp73alpha protein inhibits caspase-2 activity, preventing apoptosis and promoting tumor growth. This finding highlights TAp73alpha
Area of Science:
- Molecular Biology
- Cell Death Pathways
- Cancer Biology
Background:
- Caspase-2 is a highly conserved mammalian caspase activated by death stimuli, preceding mitochondrial dysfunction and apoptosis.
- Caspase-2 exhibits tumor suppressor functions in vivo.
- The TAp73alpha isoform, upregulated in tumors, can repress drug-induced apoptosis in a cell-type specific manner.
Purpose of the Study:
- To investigate the interaction between TAp73alpha and caspase-2.
- To determine how TAp73alpha influences caspase-2 activity and downstream apoptotic events.
- To elucidate the role of TAp73alpha in modulating caspase-2-mediated cell death.
Main Methods:
- Assessed the effect of TAp73alpha on caspase-2 enzymatic activity.
- Quantified caspase-2-induced Bax activation and mitochondrial membrane potential loss.
- Investigated the structural domains of TAp73alpha required for caspase-2 inhibition.
Main Results:
- TAp73alpha directly represses caspase-2 enzymatic activity.
- This repression by TAp73alpha reduces caspase-2-mediated Bax activation and mitochondrial dysfunction.
- The inhibitory effect of TAp73alpha on caspase-2 requires its DNA binding and SAM domains.
Conclusions:
- TAp73alpha acts as an inhibitor of caspase-2-induced apoptosis.
- The oncogenic potential of TAp73alpha is strengthened by its ability to inhibit caspase-2, especially given its upregulation in certain tumors.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Abnormal Proliferation

